Literature DB >> 19050362

Clinical analysis of cases of empyema due to Streptococcus milleri group.

Yoshihiro Kobashi1, Kenji Mouri, Shinichi Yagi, Yasushi Obase, Mikio Oka.   

Abstract

In this study we analyzed 15 cases of empyema due to Streptococcus milleri group treated between January 2000 and December 2007. The majority (87%) were men, and the mean patient age was 62 years (range 36 to 83). An underlying disease was present in 14 of 15 cases. Six cases were complicated by pneumonia. Polymicrobial infection with S. milleri group was recognized in four patients. Most patients underwent chest tube drainage (87%), and all received antibiotic treatment (100%). The average duration of chest tube drainage was 8.4 days and that of antibiotic treatment was 14.0 days. Six cases (40%) underwent video-assisted thoracoscopic surgery for decortication. The duration of hospitalization was 19.6 days. The clinical effect of treatment was comparatively good (93%), and the prognosis was also good (mortality rate 7%).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19050362

Source DB:  PubMed          Journal:  Jpn J Infect Dis        ISSN: 1344-6304            Impact factor:   1.362


  6 in total

1.  Macrolide and clindamycin resistance in Streptococcus milleri group isolates from the airways of cystic fibrosis patients.

Authors:  Margot E Grinwis; Christopher D Sibley; Michael D Parkins; Christina S Eshaghurshan; Harvey R Rabin; Michael G Surette
Journal:  Antimicrob Agents Chemother       Date:  2010-04-19       Impact factor: 5.191

2.  Clinical Characteristics of Infections Caused by Streptococcus Anginosus Group.

Authors:  Shenghua Jiang; Min Li; Tian Fu; Fenglian Shan; Luning Jiang; Zewei Shao
Journal:  Sci Rep       Date:  2020-06-03       Impact factor: 4.379

3.  Identification of Microbiome Etiology Associated With Drug Resistance in Pleural Empyema.

Authors:  Zhaoyan Chen; Hang Cheng; Zhao Cai; Qingjun Wei; Jinlong Li; Jinhua Liang; Wenshu Zhang; Zhijian Yu; Dongjing Liu; Lei Liu; Zhenqiang Zhang; Ke Wang; Liang Yang
Journal:  Front Cell Infect Microbiol       Date:  2021-03-16       Impact factor: 5.293

Review 4.  The Clinical View on Streptococcus anginosus Group - Opportunistic Pathogens Coming Out of Hiding.

Authors:  Magdalena Pilarczyk-Zurek; Izabela Sitkiewicz; Joanna Koziel
Journal:  Front Microbiol       Date:  2022-07-08       Impact factor: 6.064

5.  Acute phlegmonous esophagitis as a rare but threatening complication of chemoradiotherapy: report of a case.

Authors:  Hiroyuki Karimata; Tadashi Nishimaki; Akehiro Oshita; Masayoshi Nagahama; Hideaki Shimoji; Morihiko Inamine; Tadatsugu Kinjyo
Journal:  Surg Today       Date:  2013-03-07       Impact factor: 2.549

6.  The clinical features of respiratory infections caused by the Streptococcus anginosus group.

Authors:  Shingo Noguchi; Kazuhiro Yatera; Toshinori Kawanami; Kei Yamasaki; Keisuke Naito; Kentaro Akata; Ikuko Shimabukuro; Hiroshi Ishimoto; Chiharu Yoshii; Hiroshi Mukae
Journal:  BMC Pulm Med       Date:  2015-10-26       Impact factor: 3.317

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.